Iontophoresis of lecithin vesicles of cyclosporin A

被引:46
作者
Boinpally, RR
Zhou, SL
Devraj, G
Anne, PK
Poondru, S
Jasti, BR
机构
[1] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
[2] Kakatiya Univ, Coll Pharm, Warangal 506009, Andhra Pradesh, India
[3] Univ Pacific, TJL Sch Pharm & Hlth Sci, Stockton, CA 95211 USA
关键词
cyclosporin A; site-specific immunosuppression; topical delivery; lecithin vesicles; microemulsion; iontophoresis; electroosmosis;
D O I
10.1016/j.ijpharm.2004.01.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Site-specific immunosuppression with topical cyclosporin A (CsA) has broad clinical implications in the treatment of skin disorders like psoriasis, pyoderma gangrenosum, lichen planus, cutaneous graft-versus-host disease and contact hypersensitivity and the temporary treatment of skin allografts on burn wounds. However, like any other peptide drug, its skin delivery is hindered by the barrier property of stratum corneum and the physicochemical properties of CsA. We have attempted to deliver CsA across human cadaver epidermis in vitro using colloidal systems like microemulsion and lecithin vesicles and iontophoresis. Although, passive diffusion did not result in permeation of quantifiable amounts of CsA, anodal iontophoresis of the negatively charged colloidal systems facilitated the permeation. Electroosmosis and compromised epidermis might have contributed to the higher skin flux. Lecithin vesicles were better than microemulsion for the iontophoretic delivery of CsA and appear to have potential in site-specific immunosuppression. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 29 条
[11]  
DEPROST Y, 1986, LANCET, V2, P803
[12]   ENHANCED PERCUTANEOUS-ABSORPTION OF A NOVEL TOPICAL CYCLOSPORINE-A FORMULATION AND ASSESSMENT OF ITS IMMUNOSUPPRESSIVE ACTIVITY [J].
DUNCAN, JI ;
PAYNE, SNL ;
WINFIELD, AJ ;
ORMEROD, AD ;
THOMSON, AW .
BRITISH JOURNAL OF DERMATOLOGY, 1990, 123 (05) :631-640
[13]   Effect of liposomes and niosomes on skin permeation of enoxacin [J].
Fang, JY ;
Hong, CT ;
Chiu, WT ;
Wang, YY .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 219 (1-2) :61-72
[14]   PROLONGED SURVIVAL OF ALLOGENEIC CORNEAL GRAFTS IN RABBITS TREATED WITH TOPICALLY APPLIED CYCLOSPORIN-A - SYSTEMIC ABSORPTION AND LOCAL IMMUNOSUPPRESSIVE EFFECT [J].
FOETS, B ;
MISSOTTEN, L ;
VANDERVEEREN, P ;
GOOSSENS, W .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1985, 69 (08) :600-603
[15]   Lecithin vesicular carriers for transdermal delivery of cyclosporin A [J].
Guo, JX ;
Ping, QN ;
Sun, GQ ;
Jiao, CH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 194 (02) :201-207
[16]  
HERMANN R C, 1988, Skin Pharmacology, V1, P246
[17]  
Hewitt CW, 1996, TRANSPLANT P, V28, P922
[18]   SITE-SPECIFIC IMMUNE SUPPRESSION WITH TOPICAL CYCLOSPORINE - SYNERGISM WITH COMBINED TOPICAL CORTICOSTEROID ADDED DURING THE MAINTENANCE PHASE [J].
LLULL, R ;
LEE, TP ;
VU, AN ;
BLACK, KS ;
HEWITT, CW .
TRANSPLANTATION, 1995, 59 (10) :1483-1485
[19]   Evaluation of in-vivo transdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats [J].
Nakashima, M ;
Zhao, MF ;
Ohya, H ;
Sakurai, M ;
Sasaki, H ;
Matsuyama, K ;
Ichikawa, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (11) :1143-1146
[20]   TOPICAL CYCLOSPORINE IN ALOPECIA-AREATA [J].
PARODI, A ;
REBORA, A .
ARCHIVES OF DERMATOLOGY, 1987, 123 (02) :165-166